{"hands_on_practices": [{"introduction": "Before a quantitative PCR assay can be trusted for experimental measurements, its performance must be rigorously validated. A cornerstone of this validation is the standard curve, which reveals the assay's amplification efficiency. This exercise guides you through the derivation that connects the experimentally measured slope of the standard curve to the amplification efficiency, $E$, allowing you to assess whether your assay meets the stringent quality criteria required for publication [@problem_id:5157267].", "problem": "A laboratory performing Reverse Transcription quantitative Polymerase Chain Reaction (RT-qPCR) for an RNA target evaluates assay performance using a standard curve generated from a serial dilution of an in vitro transcribed RNA calibrator of known input copy number. The cycle at quantification ($C_{q}$) is plotted against the base-$10$ logarithm of the input template quantity, yielding a linear relationship characterized by a slope and an intercept. The following experimentally observed metrics are obtained from three independent runs performed under identical Reverse Transcription (RT) and Polymerase Chain Reaction (PCR) conditions: slope $m = -3.45$ and coefficient of determination $R^{2} = 0.998$.\n\nStarting from first principles that relate exponential amplification per cycle to threshold crossing and standard-curve linearity, derive the analytical expression that connects the slope $m$ to the per-cycle amplification efficiency $E$ (defined as the fractional increase per cycle, such that a perfectly doubling reaction has $E = 1$). Then, compute $E$ from the given slope and state whether the efficiency and linearity meet the acceptance criteria typically required by the Minimum Information for Publication of Quantitative Real-Time Polymerase Chain Reaction Experiments (MIQE) guidelines. In your final numerical result, express $E$ as a decimal fraction and round your answer to three significant figures. No units are required in the final numerical answer.", "solution": "The problem requires the derivation of an analytical expression connecting the slope of a qPCR standard curve to the amplification efficiency, the calculation of this efficiency from a given slope, and an assessment of the assay's performance against standard guidelines. The validation confirms that the problem is scientifically grounded, well-posed, objective, and contains sufficient information for a unique solution.\n\nFirst, we establish the fundamental principles of exponential amplification in Polymerase Chain Reaction (PCR). Let $N_0$ be the initial number of cDNA template molecules present at the beginning of the PCR step (cycle $0$). The per-cycle amplification efficiency, $E$, is defined as the fractional increase in the number of amplicons per cycle. The amplification factor per cycle is therefore $(1+E)$. For a perfect reaction where the number of amplicons doubles each cycle, the amplification factor is $2$, which corresponds to $E = 1$ according to the problem's definition $(1+1 = 2)$.\n\nThe number of amplicons, $N_c$, after $c$ cycles of PCR can be modeled by the geometric progression:\n$$N_c = N_0 (1+E)^c$$\n\nThe quantification cycle, $C_q$, is defined as the fractional cycle number at which the fluorescence signal from the amplified DNA crosses a predetermined threshold. This fluorescence is directly proportional to the amount of amplified DNA, $N_c$. Therefore, at $c = C_q$, the number of amplicons reaches a constant threshold quantity, $N_q$.\n$$N_q = N_0 (1+E)^{C_q}$$\n\nThe problem states that the standard curve is generated by plotting $C_q$ (on the y-axis) against the base-$10$ logarithm of the input template quantity (on the x-axis). Let the initial RNA template quantity be $Q_0$. The initial cDNA quantity for PCR, $N_0$, is proportional to $Q_0$, related by the efficiency of the reverse transcription (RT) step, $\\eta_{RT}$, such that $N_0 = \\eta_{RT} Q_0$. Substituting this into the equation gives:\n$$N_q = (\\eta_{RT} Q_0) (1+E)^{C_q}$$\n\nTo derive the relationship for the standard curve, we solve for $C_q$ as a function of $Q_0$. We begin by taking the base-$10$ logarithm of both sides of the equation:\n$$\\log_{10}(N_q) = \\log_{10}\\left((\\eta_{RT} Q_0) (1+E)^{C_q}\\right)$$\nUsing the properties of logarithms, we can expand the right side:\n$$\\log_{10}(N_q) = \\log_{10}(\\eta_{RT}) + \\log_{10}(Q_0) + \\log_{10}\\left((1+E)^{C_q}\\right)$$\n$$\\log_{10}(N_q) = \\log_{10}(\\eta_{RT}) + \\log_{10}(Q_0) + C_q \\log_{10}(1+E)$$\n\nNow, we rearrange the equation to express $C_q$ in terms of $\\log_{10}(Q_0)$, which corresponds to the form of a linear equation, $y = mx+b$, where $y = C_q$ and $x = \\log_{10}(Q_0)$.\n$$C_q \\log_{10}(1+E) = \\log_{10}(N_q) - \\log_{10}(\\eta_{RT}) - \\log_{10}(Q_0)$$\n$$C_q = -\\left(\\frac{1}{\\log_{10}(1+E)}\\right) \\log_{10}(Q_0) + \\left(\\frac{\\log_{10}(N_q) - \\log_{10}(\\eta_{RT})}{\\log_{10}(1+E)}\\right)$$\n\nBy comparing this equation to the standard linear form $y = mx+b$, we can identify the slope $m$ as the coefficient of the $x$ term, $\\log_{10}(Q_0)$.\nThe analytical expression that connects the slope $m$ to the per-cycle amplification efficiency $E$ is therefore:\n$$m = -\\frac{1}{\\log_{10}(1+E)}$$\n\nNext, we compute the value of $E$ using the experimentally observed slope, $m = -3.45$. We rearrange the derived expression to solve for $E$:\n$$-3.45 = -\\frac{1}{\\log_{10}(1+E)}$$\n$$3.45 = \\frac{1}{\\log_{10}(1+E)}$$\n$$\\log_{10}(1+E) = \\frac{1}{3.45}$$\nTo solve for $E$, we exponentiate both sides with base $10$:\n$$1+E = 10^{\\left(\\frac{1}{3.45}\\right)}$$\n$$E = 10^{\\left(\\frac{1}{3.45}\\right)} - 1$$\n\nNow, we calculate the numerical value:\n$$E \\approx 10^{0.289855...} - 1$$\n$$E \\approx 1.94916... - 1$$\n$$E \\approx 0.94916...$$\nRounding to three significant figures as requested, we obtain:\n$$E \\approx 0.949$$\n\nFinally, we assess if the assay performance meets the acceptance criteria set by the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines. The two key metrics provided are the coefficient of determination, $R^2$, and the slope, $m$, from which we calculated the efficiency.\n\n1.  **Linearity**: The coefficient of determination, $R^2$, quantifies the goodness of fit of the linear regression to the data points of the standard curve. The MIQE guidelines generally stipulate that $R^2$ should be greater than $0.980$, with values greater than $0.990$ being highly desirable. The observed value is $R^2 = 0.998$, which indicates excellent linearity and far exceeds the minimum acceptance criterion.\n\n2.  **Amplification Efficiency**: The efficiency of the PCR is a critical performance parameter. The MIQE guidelines recommend an amplification efficiency between $90\\%$ and $110\\%$. In the context of the problem's definition, where $E=1$ corresponds to $100\\%$ efficiency, this range translates to $0.90 \\le E \\le 1.10$. A slope of a perfect reaction ($E=1$) would be $m = -1/\\log_{10}(2) \\approx -3.32$. Our calculated efficiency is $E \\approx 0.949$. This corresponds to an efficiency of $94.9\\%$, which falls squarely within the acceptable range of $90\\%$ to $110\\%$.\n\nIn conclusion, both the linearity of the standard curve ($R^2 = 0.998$) and the amplification efficiency ($E \\approx 0.949$) meet the stringent quality control criteria typically required by the MIQE guidelines, indicating a robust and reliable RT-qPCR assay.", "answer": "$$\\boxed{0.949}$$", "id": "5157267"}, {"introduction": "One of the most powerful applications of RT-qPCR is measuring the relative change in gene expression between different conditions, such as in a patient versus a healthy control. This is typically achieved by converting raw cycle threshold data into a relative fold-change value using the $\\Delta\\Delta C_t$ method. This practice challenges you to derive the underlying formula from the first principles of exponential amplification, solidifying your understanding of how this ubiquitous analysis method transforms raw data into biologically meaningful results [@problem_id:5157235].", "problem": "A clinical immunodiagnostics laboratory is quantifying messenger ribonucleic acid (mRNA) expression of a cytokine target in peripheral blood mononuclear cells from a patient relative to a healthy control using Reverse Transcription–quantitative Polymerase Chain Reaction (RT–qPCR). Complementary deoxyribonucleic acid (cDNA) is synthesized from the RNA by reverse transcription, and the cDNA is amplified and monitored in real time. The Cycle threshold (Ct) is defined as the cycle number at which the fluorescence signal crosses a fixed detection threshold. Assume the following conditions hold: both the target gene and the chosen housekeeping reference gene amplify with an identical per-cycle amplification factor $E$; the fluorescence detection threshold is the same across all runs; and the reference gene is invariant across conditions such that normalization to it reflects relative target abundance.\n\nIn the patient sample and the healthy control, the laboratory reports the normalized cycle thresholds as $\\Delta Ct_{\\text{sample}}=5$ and $\\Delta Ct_{\\text{control}}=7$, respectively, where $\\Delta Ct$ is defined as the difference between the target and reference gene cycle thresholds in the same specimen. Assume an ideal amplification factor of $E=2$.\n\nStarting only from the exponential amplification principle of Polymerase Chain Reaction (PCR) and the definition of the cycle threshold, derive the expression for the relative fold change in target abundance of the patient sample versus the healthy control using the $\\Delta\\Delta Ct$ method, and then evaluate it for the provided values. Provide the final fold change as a single dimensionless number. Do not round; report the exact value.", "solution": "The problem is valid as it is scientifically grounded in the principles of molecular diagnostics, well-posed with sufficient and consistent data, and objectively stated. We can thus proceed to a full derivation and solution.\n\nThe fundamental principle of the Polymerase Chain Reaction (PCR) is the exponential amplification of a deoxyribonucleic acid (DNA) target. The number of amplicon molecules, $N(C)$, after $C$ cycles of amplification is given by the equation:\n$$N(C) = N_0 \\times E^{C}$$\nwhere $N_0$ is the initial number of target molecules and $E$ is the per-cycle amplification factor.\n\nIn quantitative PCR (qPCR), fluorescence is monitored in real time. The Cycle threshold, $Ct$, is defined as the cycle number at which the fluorescence signal, which is proportional to the amount of amplicon, crosses a fixed detection threshold. Let $N_T$ represent the number of amplicon molecules corresponding to this threshold. At $C=Ct$, we have:\n$$N_T = N_0 \\times E^{Ct}$$\nThis equation can be rearranged to express the initial quantity of target molecules, $N_0$, as a function of the measured $Ct$ value:\n$$N_0 = N_T \\times E^{-Ct}$$\nThe problem states that the factor $E$ and the threshold $N_T$ are constant for all reactions.\n\nThe goal is to determine the relative abundance of a target mRNA in a patient sample compared to a healthy control. This is done by normalizing the target gene expression to a housekeeping reference gene, whose expression is assumed to be stable across different conditions.\n\nLet us denote the initial quantities of the target and reference gene transcripts in the patient sample as $N_{0, \\text{target, sample}}$ and $N_{0, \\text{ref, sample}}$, respectively. The corresponding cycle thresholds are $Ct_{\\text{target, sample}}$ and $Ct_{\\text{ref, sample}}$. The normalized abundance of the target gene in the patient sample is the ratio of the initial quantity of the target to the initial quantity of the reference gene:\n$$ \\text{Normalized Abundance}_{\\text{sample}} = \\frac{N_{0, \\text{target, sample}}}{N_{0, \\text{ref, sample}}} $$\nSubstituting the expression for $N_0$ for both genes:\n$$ \\text{Normalized Abundance}_{\\text{sample}} = \\frac{N_T \\times E^{-Ct_{\\text{target, sample}}}}{N_T \\times E^{-Ct_{\\text{ref, sample}}}} = E^{(Ct_{\\text{ref, sample}} - Ct_{\\text{target, sample}})} $$\nThe problem defines the normalized cycle threshold as $\\Delta Ct = Ct_{\\text{target}} - Ct_{\\text{ref}}$. Therefore, we can write the exponent as $Ct_{\\text{ref, sample}} - Ct_{\\text{target, sample}} = - (Ct_{\\text{target, sample}} - Ct_{\\text{ref, sample}}) = -\\Delta Ct_{\\text{sample}}$.\nThus, the normalized abundance in the sample is:\n$$ \\text{Normalized Abundance}_{\\text{sample}} = E^{-\\Delta Ct_{\\text{sample}}} $$\nSimilarly, for the healthy control, the normalized abundance is:\n$$ \\text{Normalized Abundance}_{\\text{control}} = E^{-\\Delta Ct_{\\text{control}}} $$\nThe relative fold change in target abundance of the patient sample versus the healthy control is the ratio of their normalized abundances:\n$$ \\text{Fold Change} = \\frac{\\text{Normalized Abundance}_{\\text{sample}}}{\\text{Normalized Abundance}_{\\text{control}}} = \\frac{E^{-\\Delta Ct_{\\text{sample}}}}{E^{-\\Delta Ct_{\\text{control}}}} $$\nUsing the properties of exponents, this simplifies to:\n$$ \\text{Fold Change} = E^{(-\\Delta Ct_{\\text{sample}} - (-\\Delta Ct_{\\text{control}}))} = E^{(\\Delta Ct_{\\text{control}} - \\Delta Ct_{\\text{sample}})} $$\nThis is the derived expression for the relative fold change. This is the core of the $\\Delta\\Delta Ct$ method. If we define $\\Delta\\Delta Ct = \\Delta Ct_{\\text{sample}} - \\Delta Ct_{\\text{control}}$, the expression can be written as:\n$$ \\text{Fold Change} = E^{-\\Delta\\Delta Ct} $$\nWe now evaluate this expression for the provided values:\nThe amplification factor is given as ideal, $E = 2$.\nThe normalized cycle threshold for the patient sample is $\\Delta Ct_{\\text{sample}} = 5$.\nThe normalized cycle threshold for the healthy control is $\\Delta Ct_{\\text{control}} = 7$.\n\nFirst, we calculate the $\\Delta\\Delta Ct$ value:\n$$ \\Delta\\Delta Ct = \\Delta Ct_{\\text{sample}} - \\Delta Ct_{\\text{control}} = 5 - 7 = -2 $$\nNext, we substitute the values of $E$ and $\\Delta\\Delta Ct$ into the derived fold change formula:\n$$ \\text{Fold Change} = E^{-\\Delta\\Delta Ct} = 2^{-(-2)} = 2^{2} $$\nFinally, we compute the exact numerical value:\n$$ \\text{Fold Change} = 4 $$\nThis result indicates a $4$-fold increase in the expression of the target mRNA in the patient sample relative to the healthy control.", "answer": "$$\\boxed{4}$$", "id": "5157235"}, {"introduction": "A critical challenge in quantifying RNA with RT-qPCR is to ensure that the signal originates from the intended mRNA template and not from contaminating genomic DNA (gDNA). The 'no-reverse transcriptase' (no-RT) control is an essential tool for detecting and assessing this contamination. This exercise demonstrates how to use the cycle threshold ($C_t$) shift between samples with and without DNase treatment to precisely quantify the fraction of residual gDNA, a vital skill for ensuring the accuracy of your gene expression data [@problem_id:5157250].", "problem": "A clinical molecular diagnostics laboratory is quantifying a messenger ribonucleic acid (mRNA) target in human peripheral blood mononuclear cells using real-time quantitative Reverse Transcription Polymerase Chain Reaction (RT-qPCR). To assess residual deoxyribonucleic acid (DNA) contamination after Deoxyribonuclease (DNase) treatment, the laboratory runs “no reverse transcription” (no-RT) controls in parallel. In a no-RT control, any amplification signal arises only from DNA contamination or non-specific amplification, not from RNA-derived complementary DNA (cDNA).\n\nAssume the following foundational facts:\n- Polymerase Chain Reaction (PCR) is an exponential process: after $k$ cycles, the quantity of amplicon is proportional to the initial amplifiable template quantity multiplied by a per-cycle amplification factor $(1+E)$, where $E$ is the amplification efficiency per cycle defined such that $E=1$ corresponds to perfect doubling.\n- In real-time PCR, the cycle threshold ($\\mathrm{Ct}$) is the cycle index $k$ at which the fluorescence crosses a fixed detection threshold. For a fixed threshold across runs and a constant $(1+E)$ within an assay, $\\mathrm{Ct}$ is inversely related to the logarithm of the initial template quantity.\n- A standard curve obtained by running known input quantities yields a linear relation between $\\mathrm{Ct}$ and $\\log_{10}(\\text{initial quantity})$ with slope $m$ (negative under typical conditions). The slope encodes the assay’s amplification factor $(1+E)$.\n\nFor a single gene-specific assay, the standard curve slope measured under the same conditions is $m=-3.45$. Two technical replicates of the no-RT control were run on the same RNA preparation before DNase treatment, yielding $\\mathrm{Ct}$ values $30.2$ and $30.5$. Two technical replicates of the no-RT control were run on the same RNA preparation after DNase treatment, yielding $\\mathrm{Ct}$ values $36.7$ and $36.3$. Assume identical thresholds, identical reaction volumes, and constant amplification efficiency across these runs.\n\nUsing only the fundamental facts above:\n- Derive, from first principles, an expression for the residual contamination fraction $f$ defined as the ratio of the amplifiable DNA template quantity remaining after DNase treatment to that present before DNase treatment, expressed in terms of the $\\mathrm{Ct}$ shift and the standard curve slope $m$.\n- Evaluate $f$ numerically using the replicate data by first averaging the $\\mathrm{Ct}$ values within each condition and then applying your derived expression.\n\nExpress the final value of $f$ as a dimensionless decimal and round your answer to $4$ significant figures.", "solution": "The problem asks for the derivation of an expression for the residual DNA contamination fraction, $f$, and its numerical evaluation based on provided real-time quantitative PCR (RT-qPCR) data.\n\nFirst, we derive the expression for $f$ from first principles. The fundamental equation of exponential PCR amplification states that the quantity of amplicon, $Q_k$, after $k$ cycles is proportional to the initial quantity of amplifiable template, $Q_0$. Using the notation from the problem statement, where the per-cycle amplification factor is $(1+E)$, we have:\n$$Q_k = Q_0 (1+E)^k$$\nHere, $E$ represents the amplification efficiency, with $E=1$ corresponding to perfect doubling.\n\nIn real-time PCR, the cycle threshold, $\\mathrm{Ct}$, is the fractional cycle number at which the fluorescence signal, which is proportional to the amplicon quantity, crosses a fixed threshold. Let $Q_{\\text{threshold}}$ be the quantity of amplicon at this threshold. Then, for any given sample, the following relation holds:\n$$Q_{\\text{threshold}} = Q_0 (1+E)^{\\mathrm{Ct}}$$\n\nWe are comparing two conditions: a sample before DNase treatment and a sample after DNase treatment. Let's denote the initial quantity of DNA template before treatment as $Q_{0, \\text{before}}$ and after treatment as $Q_{0, \\text{after}}$. The corresponding measured cycle thresholds are $\\mathrm{Ct}_{\\text{before}}$ and $\\mathrm{Ct}_{\\text{after}}$, respectively. The problem states that the amplification efficiency $E$ and the detection threshold (implying a constant $Q_{\\text{threshold}}$) are identical across these runs. Therefore, we can write two equations:\n$$Q_{\\text{threshold}} = Q_{0, \\text{before}} (1+E)^{\\mathrm{Ct}_{\\text{before}}} \\quad (1)$$\n$$Q_{\\text{threshold}} = Q_{0, \\text{after}} (1+E)^{\\mathrm{Ct}_{\\text{after}}} \\quad (2)$$\n\nSince the left-hand sides are equal, we can equate the right-hand sides:\n$$Q_{0, \\text{before}} (1+E)^{\\mathrm{Ct}_{\\text{before}}} = Q_{0, \\text{after}} (1+E)^{\\mathrm{Ct}_{\\text{after}}}$$\n\nThe residual contamination fraction, $f$, is defined as the ratio of the amplifiable DNA template quantity remaining after treatment to that present before treatment:\n$$f = \\frac{Q_{0, \\text{after}}}{Q_{0, \\text{before}}}$$\n\nBy rearranging the equated expression, we can solve for $f$:\n$$f = \\frac{(1+E)^{\\mathrm{Ct}_{\\text{before}}}}{(1+E)^{\\mathrm{Ct}_{\\text{after}}}} = (1+E)^{\\mathrm{Ct}_{\\text{before}} - \\mathrm{Ct}_{\\text{after}}}$$\n\nLet us define the shift in cycle threshold as $\\Delta\\mathrm{Ct} = \\mathrm{Ct}_{\\text{after}} - \\mathrm{Ct}_{\\text{before}}$. Substituting this into the expression for $f$ yields:\n$$f = (1+E)^{-\\Delta\\mathrm{Ct}}$$\n\nThe next step is to relate the amplification factor $(1+E)$ to the slope $m$ of the standard curve. The problem states that the standard curve is a linear plot of $\\mathrm{Ct}$ versus $\\log_{10}(Q_0)$. To establish this relationship formally, we take the base-$10$ logarithm of the threshold equation:\n$$\\log_{10}(Q_{\\text{threshold}}) = \\log_{10}\\left(Q_0 (1+E)^{\\mathrm{Ct}}\\right)$$\n$$\\log_{10}(Q_{\\text{threshold}}) = \\log_{10}(Q_0) + \\mathrm{Ct} \\cdot \\log_{10}(1+E)$$\n\nRearranging this equation to express $\\mathrm{Ct}$ as a function of $\\log_{10}(Q_0)$:\n$$\\mathrm{Ct} \\cdot \\log_{10}(1+E) = \\log_{10}(Q_{\\text{threshold}}) - \\log_{10}(Q_0)$$\n$$\\mathrm{Ct} = \\frac{\\log_{10}(Q_{\\text{threshold}})}{\\log_{10}(1+E)} - \\frac{1}{\\log_{10}(1+E)} \\log_{10}(Q_0)$$\n\nThis equation follows the linear form $y = c + mx$, where $y = \\mathrm{Ct}$ and $x = \\log_{10}(Q_0)$. By inspection, the slope $m$ is the coefficient of the $\\log_{10}(Q_0)$ term:\n$$m = -\\frac{1}{\\log_{10}(1+E)}$$\n\nFrom this, we can solve for the amplification factor $(1+E)$:\n$$\\log_{10}(1+E) = -\\frac{1}{m}$$\n$$1+E = 10^{-1/m}$$\n\nFinally, we substitute this expression for $(1+E)$ back into our equation for $f$:\n$$f = (10^{-1/m})^{-\\Delta\\mathrm{Ct}} = 10^{(-1/m) \\cdot (-\\Delta\\mathrm{Ct})}$$\n$$f = 10^{\\frac{\\Delta\\mathrm{Ct}}{m}}$$\nThis is the derived expression for the residual contamination fraction $f$ in terms of the $\\mathrm{Ct}$ shift and the standard curve slope.\n\nNow, we evaluate $f$ numerically using the provided data.\nThe given data are:\n-   Standard curve slope: $m = -3.45$.\n-   No-RT control $\\mathrm{Ct}$ values before DNase treatment: $30.2$ and $30.5$.\n-   No-RT control $\\mathrm{Ct}$ values after DNase treatment: $36.7$ and $36.3$.\n\nAs instructed, we first average the replicate $\\mathrm{Ct}$ values for each condition.\nThe average $\\mathrm{Ct}$ before treatment is:\n$$\\overline{\\mathrm{Ct}}_{\\text{before}} = \\frac{30.2 + 30.5}{2} = \\frac{60.7}{2} = 30.35$$\nThe average $\\mathrm{Ct}$ after treatment is:\n$$\\overline{\\mathrm{Ct}}_{\\text{after}} = \\frac{36.7 + 36.3}{2} = \\frac{73.0}{2} = 36.5$$\n\nNext, we calculate the $\\mathrm{Ct}$ shift, $\\Delta\\mathrm{Ct}$:\n$$\\Delta\\mathrm{Ct} = \\overline{\\mathrm{Ct}}_{\\text{after}} - \\overline{\\mathrm{Ct}}_{\\text{before}} = 36.5 - 30.35 = 6.15$$\n\nWe substitute the numerical values of $\\Delta\\mathrm{Ct}$ and $m$ into our derived formula for $f$:\n$$f = 10^{\\frac{6.15}{-3.45}} = 10^{-1.78260869...}$$\n\nCalculating the numerical value:\n$$f \\approx 0.01649518$$\n\nThe problem requires the answer to be rounded to $4$ significant figures. The first four significant figures are $1$, $6$, $4$, and $9$. The fifth digit is $5$, so we round up the last significant digit.\n$$f \\approx 0.01650$$", "answer": "$$\\boxed{0.01650}$$", "id": "5157250"}]}